Results 51 to 60 of about 603,581 (184)

Inhibition of SARS‐CoV‐2‐mediated thromboinflammation by CLEC2.Fc

EMBO Molecular Medicine, 2023
Thromboinflammation is the major cause of morbidity and mortality in COVID‐19 patients, and post‐mortem examination demonstrates the presence of platelet‐rich thrombi and microangiopathy in visceral organs.
Pei‐Shan Sung, Cheng‐Pu Sun, Mi‐Hua Tao, Shie‐Liang Hsieh   +3 more
doaj   +1 more source

Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe [PDF]

, 2021
Vikram Thakur, Shivam Bhola, Pryanka Thakur, Sanjay K. S. Patel, Saurabh Kulshrestha, Radha Kanta Ratho, Pradeep Kumar   +6 more
openalex   +1 more source

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape [PDF]

, 2021
Zhiqiang Ku, Xuping Xie, Edgar Davidson, Xiaohua Ye, Hang Su, Vineet D. Menachery, Yize Li, Zihao Yuan, Xianwen Zhang, Antonio E. Muruato, Ariadna Grinyo i Escuer, Breanna Tyrell, Kyle Doolan, Benjamin J. Doranz, Daniel Wrapp, Paul Bates, Jason S. McLellan, Susan R. Weiss, Ningyan Zhang, Pei‐Yong Shi, Zhiqiang An   +20 more
openalex   +1 more source

Immunouniverse of SARS-CoV-2

Immunological Medicine, 2022
SARS-CoV-2 virus has become a global health problem that has caused millions of deaths worldwide. The infection can present with multiple clinical features ranging from asymptomatic or mildly symptomatic patients to patients with severe or critical illness that can even lead to death.
Dennis Jiménez, Marbel Torres Arias
openaire   +3 more sources

Structural investigations of proteins encoded by SARS‐CoV‐2

FEBS Open Bio, 2022
It is hard to overestimate the influence of the COVID‐19 pandemic on scientific research in the last two and a half years. Within a few weeks after the first cases of the disease were reported, the causative agent, now known as SARS‐CoV‐2, was identified,
Alexander Wlodawer
doaj   +1 more source

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses [PDF]

, 2021
Sham Nambulli, Yufei Xiang, Natasha L. Tilston‐Lunel, Linda J. Rennick, Zhe Sang, William B. Klimstra, Douglas S. Reed, Nicholas A. Crossland, Yi Shi, W. Paul Duprex   +9 more
openalex   +1 more source

Sarcoidosis following SARS‐CoV‐2 infection: Cause or consequence?

Respirology Case Reports, 2022
The COVID‐19 pandemic has been a worldwide medical challenge. Despite rapid advancements, many questions regarding SARS‐CoV‐2 interaction with other pathologies and long‐term consequences remained unanswered. Sarcoidosis is a multi‐systemic granulomatous
Esther Palones, Virginia Pajares, Laura López, Diego Castillo, Alfons Torrego   +4 more
doaj   +1 more source

Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection [PDF]

, 2021
Deeksha Munnur, Qi Wen Teo, Denzel Eggermont, Horace H.Y. Lee, Fabien Théry, Julian Ho, Sophie Wilhelmina van Leur, Wilson W. Ng, Lewis Siu, Antje Beling, Hidde L. Ploegh, Adán Pinto-Fernández, Andreas Damianou, Benedikt M. Kessler, Francis Impens, Chris Ka Pun Mok, Sumana Sanyal   +16 more
openalex   +1 more source

Transplantation of hearts from SARS‐CoV‐2 positive donors

ESC Heart Failure, 2023
Incidence of SARS‐CoV‐2 remains high in the population. Consequently, an increasing percentage of reported organ donors are also SARS‐CoV‐2 positive.
Payam Akhyari, Moritz Benjamin Immohr, Florian Bönner, Petra Reinecke, Artur Lichtenberg, Udo Boeken   +5 more
doaj   +1 more source

Infección por SARS-COV-2 en trabajadores de la salud: análisis de riesgo epidemiológico en una institución de alta complejidad de Bogotá, Colombia, 2020

Infectio, 2022
Objective: To determine the incidence of SARS-CoV-2 infection and its association with sociodemographic, clinical, and occupational characteristics in health workers (HCWs) in the COVID-19 risk area.Material and method: Longitudinal analytical study in a
Milcíades Ibáñez-Pinilla
doaj   +1 more source